/ Print /

MHE Articles

Patients who need PCSK9 inhibitors can’t get themStudy: PCSK9 inhibitors are being rejected by insurers at very high rates even in high-risk patients like those with familial hypercholesterolemia.
Researchers identify more effective, cost-efficient test for breast cancer riskNew findings reveal this genetic test to assess breast cancer risk could be more effective than others.
ACA uncertainty impacts rate of insured: What health execs should knowA Gallup-Healthways poll shows it will be important to monitor the uninsured trends in the coming months as the ACA hangs in the balance.
How to connect with the sickest, neediest patientsA new Commonwealth Fund survey on how Medicaid changes could affect this population, has experts weighing in on ways to resolve the healthcare disconnect.
Zika vaccine progress: Five things to knowTo date, the CDC reports 5,234 Zika virus disease cases in the United States and 36,526 cases in U.S. territories. Here’s where we are in the vaccine development process.
How to make health price information more accessible to consumersNational survey and surveys in New York State, Florida, Texas, and New Hampshire point to a need for more actionable price information.
How one hospital reduced pediatric epilepsy emergency visits, admissionsNationwide Children’s Hospital sees dramatic drop in ED visits and inpatient admissions for epilepsy patients with collaborative quality improvement project.
Pop health project finds new ties between health, finances, locationPopulation health data strategies are finding connections between better health and better quality of living.
Hospital pop health program increases cancer screenings, patient engagementA hospital system is adapting population health data to create a blueprint for a cost savings patient care program.
Game-changing cholesterol-buster further reduces heart attack, strokeA new outcomes study shows that the PCSK9 inhibitor Repatha significantly reduced the risk of hard major adverse cardiovascular events in high-risk patients by 20%.